Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study details soft-tissue sarcoma (STS) national statistics in Japan, revealing key epidemiological and prognostic factors. Findings highlight survival associations with patient and tumor characteristics, informing future research and patient care.
Area Of Science
- Oncology
- Epidemiology
- Public Health
Background
- No prior national characterization of soft-tissue sarcoma (STS) existed.
- This study utilized Japan's National Cancer Registry for nationwide STS statistics.
Purpose Of The Study
- To outline the epidemiology, clinical features, treatment, and prognosis of STS in Japan.
- To identify significant factors influencing STS prognosis.
Main Methods
- Analysis of 23,522 STS patients from the National Cancer Registry (2016-2019).
- Data extraction included demographics, tumor details, hospital characteristics, treatment, and outcomes.
- International Classification of Diseases-Oncology, Third Edition codes were used for patient identification.
Main Results
- STS shows a slight male predominance with an age-adjusted incidence of 3.22/100,000/year.
- Liposarcoma was the most common subtype; common locations included soft tissue, skin, and retroperitoneum.
- Survival was significantly associated with sex, age, tumor location, facility type, hospital volume, diagnosis reason, disease extent, and surgical treatment.
Conclusions
- This is the first comprehensive report on STS in Japan using national registry data.
- Findings provide essential data for understanding STS and informing strategies for aging populations globally.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...